Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 197 of 1,261
  1. US 11639504

    Methods and compositions for regulation of transgene expression

    Sangamo Therapeutics, Inc. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  2. US 11639527

    Methods for nucleic acid sequencing

    Veracyte, Inc. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  3. US 11638760

    Pyrrolobenzodiazepine antibody conjugates

    Mersana Therapeutics, Inc. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  4. US 11639359

    Bryoid compositions, methods of making and use thereof

    Aphios Corporation · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  5. US 11638708

    Method of treatment of aggression

    Supernus Pharmaceuticals, Inc. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  6. US 11639355

    Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors

    Medshine Discovery Inc. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  7. US 11638704

    Bicyclic compounds and their use in the treatment of cancer

    TEMPEST THERAPEUTICS, INC. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  8. US 11638761

    Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy

    Dyne Therapeutics, Inc. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  9. US 11640848

    Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden

    REGENERON PHARMACEUTICALS, INC. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  10. US 11638706

    Methods for treating Huntington's disease

    PTC THERAPEUTICS, INC. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  11. US 11639490

    Device and method for producing and purifying exosomes

    Foundation for Cardiological Research and Education (FCRE) · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  12. US 11639347

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  13. US 11638690

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  14. US 11638747

    WT1 vaccine

    Inovio Pharmaceuticals, Inc. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  15. US 11639364

    Potent sialyltransferase inhibitors

    Stichting Radboud universitair medisch centrum · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  16. US 11638753

    Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

    PDS Biotechnology Corporation · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  17. US 2023130736

    METHODS OF TREATING MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Apr 27, 2023 · Expires Apr 22, 2043

    granted
  18. US 11634396

    Opioid receptor modulators

    EPIODYNE, INC. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  19. US 11634688

    Methods and compositions for inducing hematopoietic cell differentiation

    Fate Therapeutics, Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  20. US 11634507

    Dendritic gold nanoparticles and methods of synthesis

    The Board of Regents of the University of Oklahoma · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  21. US 11633479

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  22. US 11633480

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  23. US 11633483

    Modulators of PCSK9 expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  24. US 11633501

    Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.